Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Login and Edit functionaility is currently unavailable.

William Francis Pirl, M.D.

Co-Author

This page shows the publications co-authored by William Pirl and Inga Lennes.
Connection Strength

3.508
  1. Quality of psychosocial services in cancer centers: Today and tomorrow. Cancer. 2016 06 15; 122(12):1807-8.
    View in: PubMed
    Score: 0.703
  2. ASCO Quality Oncology Practice Initiative (QOPI) quality measures for smoking cessation and survival in metastatic NSCLC. J Clin Oncol. 2011 May 20; 29(15_suppl):6074.
    View in: PubMed
    Score: 0.501
  3. A Systematic Review of Adherence to Oral Antineoplastic Therapies. Oncologist. 2016 Mar; 21(3):354-76.
    View in: PubMed
    Score: 0.174
  4. Psychological factors at early stage of treatment as predictors of receiving chemotherapy at the end of life. Psychooncology. 2015 Dec; 24(12):1731-7.
    View in: PubMed
    Score: 0.165
  5. Processes of discontinuing chemotherapy for metastatic non-small-cell lung cancer at the end of life. J Oncol Pract. 2015 May; 11(3):e405-12.
    View in: PubMed
    Score: 0.164
  6. Exploring the relationship between fear of cancer recurrence and sleep quality in cancer survivors. J Psychosoc Oncol. 2015; 33(3):297-309.
    View in: PubMed
    Score: 0.161
  7. Documentation of oral versus intravenous chemotherapy plans in patients with metastatic non-small-cell lung cancer. J Oncol Pract. 2014 Mar; 10(2):e103-6.
    View in: PubMed
    Score: 0.151
  8. Depression, survival, and epidermal growth factor receptor genotypes in patients with metastatic non-small cell lung cancer. Palliat Support Care. 2013 Jun; 11(3):223-9.
    View in: PubMed
    Score: 0.141
  9. Electronic prompt to improve outpatient code status documentation for patients with advanced lung cancer. J Clin Oncol. 2013 Feb 20; 31(6):710-5.
    View in: PubMed
    Score: 0.140
  10. Depression and survival in metastatic non-small-cell lung cancer: effects of early palliative care. J Clin Oncol. 2012 Apr 20; 30(12):1310-5.
    View in: PubMed
    Score: 0.133
  11. Anxiety disorders in long-term survivors of adult cancers. Psychosomatics. 2011 Sep-Oct; 52(5):417-23.
    View in: PubMed
    Score: 0.128
  12. Tumor epidermal growth factor receptor genotype and depression in stage IV non-small cell lung cancer. Oncologist. 2011; 16(9):1299-306.
    View in: PubMed
    Score: 0.127
  13. Early palliative care, depression, and survival in metastatic NSCLC. J Clin Oncol. 2011 May 20; 29(15_suppl):6024.
    View in: PubMed
    Score: 0.125
  14. Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative care. J Clin Oncol. 2011 Jun 10; 29(17):2319-26.
    View in: PubMed
    Score: 0.125
  15. Randomized Trial of a Smartphone Mobile App to Improve Symptoms and Adherence to Oral Therapy for Cancer. J Natl Compr Canc Netw. 2020 02; 18(2):133-141.
    View in: PubMed
    Score: 0.057
  16. Patient Experiences With Oral Chemotherapy: Adherence, Symptoms, and Quality of Life. J Natl Compr Canc Netw. 2019 03 01; 17(3):221-228.
    View in: PubMed
    Score: 0.054
  17. Are cancer survivors following the national comprehensive cancer network health behavior guidelines? An assessment of patients attending a cancer survivorship clinic. J Psychosoc Oncol. 2018 Jan-Feb; 36(1):64-81.
    View in: PubMed
    Score: 0.050
  18. The relationship between physical and psychological symptoms and health care utilization in hospitalized patients with advanced cancer. Cancer. 2017 Dec 01; 123(23):4720-4727.
    View in: PubMed
    Score: 0.049
  19. Treatment Satisfaction and Adherence to Oral Chemotherapy in Patients With Cancer. J Oncol Pract. 2017 05; 13(5):e474-e485.
    View in: PubMed
    Score: 0.047
  20. Fear of recurrence or progression as a link between somatic symptoms and perceived stress among cancer survivors. Support Care Cancer. 2017 05; 25(5):1401-1407.
    View in: PubMed
    Score: 0.046
  21. Symptom burden to predict health care utilization in hospitalized patients with incurable cancer. J Clin Oncol. 2016 Oct 09; 34(26_suppl):98.
    View in: PubMed
    Score: 0.045
  22. Symptom burden in hospitalized patients with advanced cancer. J Clin Oncol. 2015 Oct 10; 33(29_suppl):100.
    View in: PubMed
    Score: 0.042
  23. Sexual health communication between cancer survivors and providers: how frequently does it occur and which providers are preferred? Psychooncology. 2015 Sep; 24(9):1167-73.
    View in: PubMed
    Score: 0.040
  24. Perceptions of health status and survival in patients with metastatic lung cancer. J Pain Symptom Manage. 2014 Oct; 48(4):548-57.
    View in: PubMed
    Score: 0.038
  25. Associations among prognostic understanding, quality of life, and mood in patients with advanced cancer. Cancer. 2014 Jan 15; 120(2):278-85.
    View in: PubMed
    Score: 0.037
  26. Effect of early palliative care on chemotherapy use and end-of-life care in patients with metastatic non-small-cell lung cancer. J Clin Oncol. 2012 Feb 01; 30(4):394-400.
    View in: PubMed
    Score: 0.033
  27. Effect of early palliative care on chemotherapy utilization and end-of-life care in patients with metastatic non-small cell lung cancer (NSCLC). J Clin Oncol. 2011 May 20; 29(15_suppl):6009.
    View in: PubMed
    Score: 0.031
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.